Next Article in Journal
Impaired Expression of Cytokines as a Result of Viral Infections with an Emphasis on Small Ruminant Lentivirus Infection in Goats
Next Article in Special Issue
Recombinant Ranaviruses for Studying Evolution of Host–Pathogen Interactions in Ectothermic Vertebrates
Previous Article in Journal
Regulation of Stress Responses and Translational Control by Coronavirus
Previous Article in Special Issue
Development of Neutralization Assay Using an eGFP Chikungunya Virus
Review

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines

Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Luis Martinez-Sobrido
Viruses 2016, 8(7), 183; https://doi.org/10.3390/v8070183
Received: 18 May 2016 / Revised: 16 June 2016 / Accepted: 22 June 2016 / Published: 4 July 2016
(This article belongs to the Special Issue Replication-Competent Reporter-Expressing Viruses)
Viral vaccine vectors have shown to be effective in inducing a robust immune response against the vaccine antigen. Newcastle disease virus (NDV), an avian paramyxovirus, is a promising vaccine vector against human and veterinary pathogens. Avirulent NDV strains LaSota and B1 have long track records of safety and efficacy. Therefore, use of these strains as vaccine vectors is highly safe in avian and non-avian species. NDV replicates efficiently in the respiratory track of the host and induces strong local and systemic immune responses against the foreign antigen. As a vaccine vector, NDV can accommodate foreign sequences with a good degree of stability and as a RNA virus, there is limited possibility for recombination with host cell DNA. Using NDV as a vaccine vector in humans offers several advantages over other viral vaccine vectors. NDV is safe in humans due to host range restriction and there is no pre-existing antibody to NDV in the human population. NDV is antigenically distinct from common human pathogens. NDV replicates to high titer in a cell line acceptable for human vaccine development. Therefore, NDV is an attractive vaccine vector for human pathogens for which vaccines are currently not available. NDV is also an attractive vaccine vector for animal pathogens. View Full-Text
Keywords: Newcastle disease virus; vaccine vector; human vaccines; veterinary vaccines Newcastle disease virus; vaccine vector; human vaccines; veterinary vaccines
Show Figures

Figure 1

MDPI and ACS Style

Kim, S.-H.; Samal, S.K. Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines. Viruses 2016, 8, 183. https://doi.org/10.3390/v8070183

AMA Style

Kim S-H, Samal SK. Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines. Viruses. 2016; 8(7):183. https://doi.org/10.3390/v8070183

Chicago/Turabian Style

Kim, Shin-Hee, and Siba K. Samal. 2016. "Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines" Viruses 8, no. 7: 183. https://doi.org/10.3390/v8070183

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop